Table 1 General characteristics of the study population
Characteristic | n = 182a |
|---|---|
Demographics | |
Male | 121 (66%) |
Age (years) | 67 (60, 72) |
Body mass index (kg/m2) | 30 (26, 35) |
Simplified acute physiology score II | 35 (29, 40) |
Comorbidities | |
Cardiopathy | 21 (12%) |
 Ischemic | 18 (10%) |
 Hypertrophic | 2 (1%) |
 Left ventricular ejection fraction < 35% | 0 (0%) |
Hypertension | 105 (58%) |
 Chronic respiratory disease | 12 (6%) |
 Chronic renal failure | 14 (8%) |
Parameters on the time of the first echocardiographic assessment | |
 Hemodynamic parameters |  |
  Heart rate (bpm) | 82 (68, 104) |
  Systolic blood pressure (mmHg) | 128 (110, 153) |
  Mean blood pressure (mmHg) | 88 (76, 103) |
  Central venous pressure (mmHg) | 9 (8, 11) |
 Respiratory parameters |  |
  Tidal volume (ml/kg) | 6.6 (6.0, 7.2) |
  Positive end-expiratory pressure (cmH2O) | 12 (10, 14) |
  Plateau pressure (cmH2O) | 25 (22, 26) |
 Biology |  |
  pH | 7.37 (7.30, 7.43) |
  PaO2/FiO2 (mmHg) | 112 (87, 162) |
  PaCO2 (mmHg) | 44 (38, 52) |
  Bicarbonates (mmol/L) | 25 (23, 27) |
  Creatinin (µmol/L) | 68 (56, 87) |
  BUN (mmol/L) | 6 (5, 9) |
  Total bilirubin (µmol/L) | 7 (5, 11) |
  Troponin (ng/L) | 20 (14, 41) |
  Lactates (mmol/L) | 1.4 (1.1, 1.8) |
  White blood Cells (G/L) | 10 (7, 12) |
  Hemoglobin (g/dL) | 12(11, 13) |
  Platelets (G/L) | 245 (183, 303) |
  International normalized ratio | 1.12 (1.06, 1.20) |
  Prothrombin time (%) | 85 (76, 92) |
 Therapeutics |  |
  Vasopressors | 17 (9%) |
  Prone positioning | 65 (35%) |
  Inhaled nitric oxyde | 0 (0%) |
  Renal replacement therapy | 1 (0.5%) |
 Sequential organ failure assessment | 4 (3, 5) |
Intensive care unit mortality | 56 (31%) |